ETF comparison

IBB vs XBI

Both Healthcare.

iShares Biotechnology ETF · State Street SPDR S&P Biotech ETF

Holdings overlap

Weighted by ISIN/CUSIP
42.0 %

125 positions appear in both funds. Buying equal dollars of IBB and XBI would leave roughly 42.0% of each dollar exposed to the same underlying securities.

IBB only 67.7% Shared 42.0% XBI only 58.0%
In IBB only
131 positions
Shared
125 positions
In XBI only
29 positions

Side by side

IBB

iShares Biotechnology ETF

iShares · Healthcare

69 composite / 100
Expense ratio
0.44%
Net assets
$9.09B
TTM yield
0.22%
Top-10 conc.
54.7%
XBI

State Street SPDR S&P Biotech ETF

State Street · Healthcare

81 composite / 100
Expense ratio
0.35%
Net assets
$10.73B
TTM yield
0.37%
Top-10 conc.
20.4%

Sub-score comparison

56
Cost
65
85
Tax efficiency
85
98
Liquidity
100
36
Concentration
85
Tracking quality
IBB sub-score XBI

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

XBI is 9 bps cheaper than IBB. On a $100,000 position that's about $90/yr more in fees for IBB.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with IBB vs XBI.

Top shared holdings

125 shared in total
# Holding In IBB In XBI Overlap
1 Insmed, Inc. 3.20% 1.34% 1.34%
2 United Therapeutics Corp. 2.30% 1.24% 1.24%
3 Alnylam Pharmaceuticals, Inc. 3.99% 1.18% 1.18%
4 Natera, Inc. 2.41% 1.16% 1.16%
5 Neurocrine Biosciences, Inc. 1.18% 1.16% 1.16%
6 Regeneron Pharmaceuticals, Inc. 7.21% 1.14% 1.14%
7 Incyte Corp. 1.70% 1.13% 1.13%
8 Bridgebio Pharma, Inc. 1.13% 1.19% 1.13%
9 Ionis Pharmaceuticals, Inc. 1.11% 1.14% 1.11%
10 Revolution Medicines, Inc. 1.54% 1.11% 1.11%
11 Biogen, Inc. 2.46% 1.10% 1.10%
12 Gilead Sciences, Inc. 7.75% 1.09% 1.09%

Only in IBB

131 total
  • BlackRock Funds III 9.66%
  • Argenx SE 3.07%
  • BeOne Medicines Ltd. 1.93%
  • Illumina, Inc. 1.68%
  • Genmab A/S 1.17%
  • Medpace Holdings, Inc. 1.00%
  • Ascendis Pharma A/S 0.96%
  • Charles River Laboratories International, Inc. 0.77%
  • Bio-Techne Corp. 0.74%
  • Axsome Therapeutics, Inc. 0.66%

Only in XBI

29 total
  • TG Therapeutics Inc 1.35%
  • Celcuity Inc 1.12%
  • AbbVie Inc 1.09%
  • Viking Therapeutics Inc 1.04%
  • Immunome Inc 0.86%
  • Catalyst Pharmaceuticals Inc 0.76%
  • Viridian Therapeutics Inc 0.70%
  • Soleno Therapeutics Inc 0.67%
  • Dianthus Therapeutics Inc 0.66%
  • Ardelyx Inc 0.62%

Open IBB or XBI at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.